Upfront Genetic Testing in GI Cancers May Lower Chemo Toxicity Risk



(MedPage Today) — Genetic testing of gastrointestinal cancer patients prior to starting chemotherapy proved feasible in a prospective study and showed a signal for a reduced risk of serious side effects.
Compared with patients who received standard…



Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116942

Author :

Publish date : 2025-08-11 21:23:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version